John Haudrich
Analyst · Mike Leithead of Barclays. Your line is now open
Yes, sure. So you're right. I mean, where we stand today, is that where asset returns and interest rates would land, that could represent if we had to book the year -- the normal year-end entry today, for example, about a $200 million headwind on the pension liability. Of course, we aren't marking this to market today. There's a lot of distance between now and the end of the year when that transaction -- I mean, that evaluation would occur. So we'll have to see how that continues to play out, ideally things start to normalize a little bit and takes the pressure off there. Keep in mind that nothing regarding that actuarial calculation, for example, would change anything associated with the expense or the cash contributions we would make this year. In fact, there are changes in the CARES Act that should benefit the timing of pension contributions to some degree. And there has been some talk already in Congress about making some form of pension relief, while it may be early days in totality there, what we have seen in back in the Great Recession was that, there was adjustments made that allowed you to smooth this out over a lot longer period of time, understanding that these calculations really can be impacted by those points in time. On the cash flow side, the big things that are moving, obviously, EBITDA will be a function of two major things going on, obviously, the sales and volume -- production volume aspect of the business, but also the -- what I believe is a pretty robust recovery plan, all the things that we've identified, we got about 20 different levers that we're managing that affect, various things of the P&L of free cash flow or other uses of cash. And that represents probably hundreds of millions of dollars worth of levers that we're working. So that we would expect to be some mitigating factor on the overall cash flows of the business. But the remaining levers that you'll see within that cash flow statement under consideration are: one, the working capital, if -- depending on whether we have a V-shaped or U-shaped recovery. And I think most people are looking more of a U-shaped recovery at this point in time, that could actually yield a working capital benefit as we collect receivables on the front end of this process, replace it with lower volumes of the activity and less of investment of receivables. And if we can keep inventory trim, as we intend to do, then that should support improved working capital positions. And we obviously talked about the lower CapEx expenditures as we plan to do, and also be mindful that we have also suspended all of our asbestos related payments, which exceeded $150 million last year. So there's a lot of different levers that are flushing through that, that we think that we can help mitigate the overall impact of the pandemic.